The Global Catalog Peptides Market was valued at US$ 134.6 Million in 2022 and is projected to reach US$ 245.8 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period (2022–2029). This growth is being driven by expanding applications in drug discovery, rising demand for high-purity peptides in academic and commercial research, and advancements in solid-phase peptide synthesis technologies across biotechnology and pharmaceutical sectors.

As the biotechnology industry evolves toward precision medicine and targeted therapies, the focus is shifting to reliable suppliers of catalog peptides that enable faster research and development. These short, chemically synthesized amino acid chains are essential tools in studying protein interactions, developing vaccines, and creating novel therapeutics. In this blog, we profile the Top 10 Companies in the Catalog Peptides Industry—a blend of established manufacturers, innovative synthesizers, and global distributors pioneering efficiency and quality in peptide supply.

---

🔟 1. PolyPeptide Group

Headquarters: Malmö, Sweden
Key Offering: High-purity catalog peptides, custom synthesis, GMP-grade peptides for research and clinical use

PolyPeptide Group stands as a global leader in peptide manufacturing, providing an extensive catalog of over 1,000 standard peptides for scientific applications. Their products support research in areas like neuroscience, immunology, and oncology, serving academic labs, biotech firms, and pharmaceutical companies worldwide. With state-of-the-art facilities in Europe and the US, the company emphasizes scalability and consistency in production, ensuring peptides meet stringent purity standards above 95%. Because of their long-standing expertise since 1959, they have become a trusted partner for accelerating drug discovery pipelines.

Innovation Initiatives:

• Investment in automated peptide synthesizers to reduce lead times

• Expansion of catalog with disease-specific peptides for COVID-19 and cancer research

• Commitment to sustainable manufacturing practices, including solvent recycling

Download FREE Sample Report: Catalog Peptides Market – View in Detailed Research Report

---

9️⃣ 2. Bachem

Headquarters: Bubendorf, Switzerland
Key Offering: Catalog peptides for biochemistry, API peptides, research-grade and cosmetic peptides

Bachem offers one of the most comprehensive catalogs in the industry, featuring thousands of peptides optimized for applications in cell biology, endocrinology, and antimicrobial studies. Operating from multiple sites across Europe, North America, and Asia, they supply peptides to over 10,000 customers annually. Their focus on quality control and regulatory compliance makes them indispensable for both academic research and commercial development. Furthermore, Bachem’s integration of green chemistry principles helps minimize environmental impact while maintaining high yields.

Innovation Initiatives:

• Development of lyophilized peptide kits for easier handling in labs

• Partnerships with universities to co-develop novel peptide sequences

• Aim for carbon-neutral production by 2030 through renewable energy adoption

---

8️⃣ 3. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Synthetic peptides, peptide libraries, tools for peptide analysis and purification

Thermo Fisher Scientific dominates the catalog peptides segment through its Pierce and Sigma-Aldrich brands, providing ready-to-use peptides for proteomics, drug screening, and vaccine development. Their global distribution network ensures rapid delivery, supporting over 500,000 research projects yearly. The company’s strength lies in bundling peptides with analytical instruments, allowing researchers to streamline workflows from synthesis to characterization. However, their scale also brings challenges in customization, which they address through hybrid catalog-custom services.

Innovation Initiatives:

• Launch of AI-assisted peptide design tools for faster catalog updates

• Enhancement of purity levels to above 98% for critical applications

• Collaborations with pharma giants to supply peptides for clinical trials

---

7️⃣ 4. GenScript Biotech

Headquarters: Nanjing, China (with US operations in Piscataway, New Jersey)
Key Offering: Custom and catalog peptides, peptide arrays, modifications like cyclization and labeling

GenScript Biotech has rapidly grown into a key player by offering affordable, high-quality catalog peptides tailored for gene editing and immunotherapy research. With production facilities in Asia and North America, they cater to emerging markets while maintaining ISO-certified standards. Their catalog includes specialized peptides for CRISPR studies and antiviral applications, reflecting the biotech boom in Asia. This positioning allows them to capture a significant share in academic and startup segments.

Innovation Initiatives:

• Integration of machine learning for predictive peptide stability

• Expansion of catalog to include over 5,000 sequences by 2025

• Sustainable sourcing of raw materials to reduce ecological footprint

Download FREE Sample Report: Catalog Peptides Market – View in Detailed Research Report

---

6️⃣ 5. GL Biochem (Shanghai) Ltd.

Headquarters: Shanghai, China
Key Offering: Bulk catalog peptides, Fmoc/Boc protected amino acids, peptide reagents

GL Biochem excels in large-scale production of catalog peptides, supplying cost-effective options for industrial and research use in Asia-Pacific regions. Their extensive inventory covers standard sequences for enzyme substrates and cell-penetrating peptides, serving thousands of labs. By leveraging China’s manufacturing prowess, they offer competitive pricing without compromising on HPLC purity levels. This approach has solidified their role in supporting global supply chains for peptide-based diagnostics.

Innovation Initiatives:

• Automation of synthesis processes to increase output by 30%

• Focus on eco-friendly purification techniques

• Strategic alliances with European distributors for wider reach

---

5️⃣ 6. CSBio

Headquarters: Santa Clara, California, USA
Key Offering: GMP peptides, catalog standards for API development, analytical services

CSBio specializes in regulatory-compliant catalog peptides, bridging research and therapeutic applications with a focus on cGMP manufacturing. Their products are vital for pharmaceutical validation studies and cosmetic formulations, distributed globally through a robust logistics network. The company’s in-house expertise in peptide scaling ensures reliability for high-volume orders, making them a go-to for biotech firms transitioning from lab to market.

Innovation Initiatives:

• Development of modified peptides for enhanced bioavailability

• Certification in sustainable lab practices

• Investment in R&D for peptide therapeutics targeting chronic diseases

---

4️⃣ 7. CPC Scientific

Headquarters: Sunnyvale, California, USA
Key Offering: Peptide building blocks, catalog libraries, custom modifications

CPC Scientific provides innovative catalog peptides optimized for drug discovery, including stapled and fluorescently labeled variants. Serving the US biotech hub in Silicon Valley, they support startups and established players in oncology and infectious disease research. Their agile production model allows quick adaptation to market needs, such as peptides for mRNA vaccine platforms. This flexibility has driven their growth amid rising demand for personalized medicine tools.

Innovation Initiatives:

• Launch of peptide microarray technologies

• Green synthesis methods to lower waste

• Partnerships with academic institutions for co-innovation

Download FREE Sample Report: Catalog Peptides Market – View in Detailed Research Report

---

3️⃣ 8. JPT Peptide Technologies

Headquarters: Berlin, Germany
Key Offering: Peptide pools, catalog antigens, epitope mapping services

JPT Peptide Technologies leads in immunopeptidomics with catalog peptides designed for T-cell research and vaccine validation. Based in Europe, they supply precision tools to immunology labs worldwide, emphasizing high-throughput screening capabilities. Their catalog’s focus on infectious diseases and autoimmunity aligns with global health priorities, fostering collaborations with vaccine developers. Moreover, their commitment to data-driven peptide design enhances research accuracy.

Innovation Initiatives:

• Advancement in neoepitope peptide synthesis

• Sustainable packaging and shipping reductions

• Expansion into AI-optimized peptide sequences

---

2️⃣ 9. Auspep

Headquarters: Melbourne, Australia
Key Offering: Research peptides, cosmetic peptides, analytical grade catalogs

Auspep delivers high-quality catalog peptides to the Asia-Pacific research community, specializing in antimicrobial and skin-care applications. Their Australian facilities ensure compliance with strict quality standards, appealing to regional pharma and cosmetic industries. By offering rapid turnaround and technical support, they help researchers overcome synthesis challenges. This localized expertise positions them well in a growing market driven by health and beauty sectors.

Innovation Initiatives:

• Development of natural-derived peptide analogs

• Energy-efficient production protocols

• Collaborative projects with APAC universities

---

1️⃣ 10. Peptides International, Inc.

Headquarters: Louisville, Kentucky, USA
Key Offering: Specialty catalog peptides, fluorogenic substrates, custom research peptides

Peptides International rounds out the top tier with niche catalog offerings for protease assays and neuroscience studies. Their US-based operations provide tailored solutions to academic and industrial clients, backed by decades of synthesis experience. The company’s emphasis on innovative modifications, like D-amino acids, sets them apart in specialized research. As the market matures, their focus on education and support strengthens customer loyalty.

Innovation Initiatives:

• Creation of peptide-based diagnostics tools

• Adoption of recyclable catalysts in synthesis

• Global outreach through online peptide resources

Get Full Report Here: Catalog Peptides Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Catalog Peptides Is Innovative and Accessible

The catalog peptides market is experiencing transformative growth. While standard research peptides remain core, the sector is channeling resources into advanced modifications, AI integration, and sustainable production to meet evolving demands in therapeutics and diagnostics.

Key segments highlight this momentum. The Purity: 95% to 98% segment dominates due to its balance of cost and reliability for routine assays, while Above 98% purity gains traction in clinical applications. Applications span commercial drug development, academic research, and emerging areas like cosmetics and agriculture. Regionally, North America leads with robust R&D funding, Europe follows with regulatory expertise, and Asia-Pacific surges through manufacturing scale.

Global top players hold a substantial revenue share, with surveys indicating strong demand drivers like biotech investments, offset by challenges such as raw material costs and supply chain disruptions from geopolitical events.

📈 Key Trends Shaping the Market:

• Rapid expansion in therapeutic peptide catalogs amid precision medicine rise

• Regulatory incentives for green peptide synthesis in EU and US

• Digital platforms for peptide ordering and customization

• Strategic mergers among suppliers to enhance global distribution

Get Full Report Here: Catalog Peptides Market – View in Detailed Research Report

The companies profiled here are not only supplying essential research tools—they’re propelling the biotechnology revolution forward with cutting-edge peptide solutions.